ACENOCOUMAROL
Acenocoumarol is an oral anticoagulant that inhibits vitamin Kdependent clotting factor synthesis. It prevents thrombosis in atrial fibrillation, DVT, and prosthetic valves. Benefits include rapid onset and easy dose adjustment. Risks include bleeding, drugfood interactions, and the need for regular INR monitoring. Only GMP materials will be supplied, logistics all according to GDP.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of action
Acenocoumarol is a coumarintype vitamin K⁺ antagonist. It inhibits the vitamin K⁺ epoxide reductase complex in the liver, preventing the regeneration of reduced vitamin K⁺ that is required for gammacarboxylation of several coagulation factors (II, VII, IX and X) and anticoagulant proteins C and S. The resulting production of partially carboxylated, less active clotting factors leads to an anticoagulant effect.
Benefits and advantages
Acenocoumarol has been widely used for longterm oral anticoagulation in the prevention and treatment of thromboembolic disorders. Its relatively short halflife compared with warfarin allows more rapid adjustment of anticoagulation in response to dose changes, which may be advantageous in certain clinical settings.
Side effects and risks
The principal risk is bleeding, which can range from minor bruising to lifethreatening haemorrhage. The drug has a narrow therapeutic index and is susceptible to numerous drugdrug and drugfood interactions, requiring regular monitoring of coagulation parameters (such as INR) in clinical use. Teratogenicity and foetal bleeding risk limit use in pregnancy. Handling of the API must follow appropriate safety standards due to its potent pharmacological activity.
Only GMP materials will be supplied, logistics all according to GDP.
Datasheet
| Molecular Formula | C19H15NO6 |
|---|---|
| Molecular Weight | 353.3 g/mol |
| CAS Number | 152-72-7 |
| Storage Condition | Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light. |
| Solubility | practically insoluble |
| Purity | Purity information is available upon request (COA). |
| Synonym | ACENOCOUMAROL; 152-72-7; Acenocoumarin; Nicoumalone; Sintrom |
| IUPAC/Chemical Name | 4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]chromen-2-one |
| InChl Key | VABCILAOYCMVPS-UHFFFAOYSA-N |
| InChl Code | InChI=1S/C19H15NO6/c1-11(21)10-15(12-6-8-13(9-7-12)20(24)25)17-18(22)14-4-2-3-5-16(14)26-19(17)23/h2-9,15,22H,10H2,1H3 |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.
